Detalhe da pesquisa
1.
TP53 mutations in advanced colorectal cancer: the dark side of the moon.
Oncology
; 86(5-6): 289-94, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24924261
2.
Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma.
Eur J Nucl Med Mol Imaging
; 37(4): 736-41, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20107788
3.
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.
Eur J Nucl Med Mol Imaging
; 37(2): 203-11, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19760414
4.
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
PLoS One
; 11(4): e0151662, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27064898
5.
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC.
Cancer Biother Radiopharm
; 24(6): 659-65, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20025545
6.
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.
Eur J Nucl Med Mol Imaging
; 35(10): 1847-56, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18427807